Announcements and news from DIA 2014.
CluePoints to Launch New Web Application for Risk-Based Monitoring at DIA 2014
Techorizon to Launch Innovative TH-eClinical Suite at DIA Annual Meeting
Bracket Introducing New Mobile App and Bracket ePRO 5.1
ACM Global Central Laboratory Announces Official Opening of ACM Singapore
BioClinica Introduces Optimizer Enterprise Suite
MedNet to Unveil Multiple iMedNet EDC Delivery Options at the 2014 DIA Annual Meeting
INC Research Invites DIA Attendees to Join Them for Event
BBK Worldwide Makes Clinical Engagement Process Easier With Mobile Apps
PRA Advances to Become PRA Health Sciences
Novotech CRO Announces MOU with Korea Drug Development Fund at DIA 2014
ERT Expands Suite of eCOA Offerings to Include Bring Your Own Device (BYOD) Solution
PatientsLikeMe Launches New Services that Make Patients Partners in Medical Research
Oracle Introduces Oracle Health Sciences Data Management Workbench
ArisGlobal Announces Free Trial Registration and Disclosure Solution for ClinicalTrials.gov
SAS Analytics Empowers Researchers to Easily Manage Data in the Cloud
Pharma Improves Care by Sharing Clinical Trial Data
ERT receives 510(k) Clearance to Market its AM3 GSM Devices for use in Respiratory Clinical Trials
ArisGlobal Announces Free Trial Registration and Disclosure Solution for ClinicalTrials.gov
ArisGlobal Releases New Version of Its Unified Electronic Data Capture System
Cytel, Suvoda Announce Partnership at the Drug Information Association (DIA) 50th Annual Meeting
Two Independent Review Boards Join the WIRB-Copernicus Group
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.